These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34004174)

  • 21. Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA).
    Liu R; Jiang W; Mellins ED
    Cell Mol Immunol; 2021 Aug; 18(8):1847-1860. PubMed ID: 34117370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides.
    Ratishvili T; Quach HQ; Haralambieva IH; Suryawanshi YR; Ovsyannikova IG; Kennedy RB; Poland GA
    Vaccine; 2024 Jan; 42(2):162-174. PubMed ID: 38105139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
    Liang C; Bencurova E; Psota E; Neurgaonkar P; Prelog M; Scheller C; Dandekar T
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.
    Mei S; Ayala R; Ramarathinam SH; Illing PT; Faridi P; Song J; Purcell AW; Croft NP
    Mol Cell Proteomics; 2020 Jul; 19(7):1236-1247. PubMed ID: 32357974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery.
    Stražar M; Park J; Abelin JG; Taylor HB; Pedersen TK; Plichta DR; Brown EM; Eraslan B; Hung YM; Ortiz K; Clauser KR; Carr SA; Xavier RJ; Graham DB
    Immunity; 2023 Jul; 56(7):1681-1698.e13. PubMed ID: 37301199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases.
    Stamatakis G; Samiotaki M; Mpakali A; Panayotou G; Stratikos E
    J Proteome Res; 2020 Nov; 19(11):4398-4406. PubMed ID: 32931291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncommon P1 Anchor-featured Viral T Cell Epitope Preference within HLA-A*2601 and HLA-A*0101 Individuals.
    Zhang J; Yue C; Lin Y; Tian J; Guo Y; Zhang D; Guo Y; Ye B; Chai Y; Qi J; Zhao Y; Gao GF; Sun Z; Liu J
    Immunohorizons; 2024 Jun; 8(6):415-430. PubMed ID: 38885041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review.
    Abd El-Baky N; Amara AA; Redwan EM
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
    Weisbrod L; Capriotti L; Hofmann M; Spieler V; Dersch H; Voedisch B; Schmidt P; Knake S
    Front Immunol; 2024; 15():1386160. PubMed ID: 38779658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation.
    Yang H; Sun H; Brackenridge S; Zhuang X; Wing PAC; Quastel M; Walters L; Garner L; Wang B; Yao X; Felce SL; Peng Y; Moore S; Peeters BWA; Rei M; Canto Gomes J; Tomas A; Davidson A; Semple MG; Turtle LCW; Openshaw PJM; Baillie JK; Mentzer AJ; Klenerman P; ; Borrow P; Dong T; McKeating JA; Gillespie GM; McMichael AJ
    Sci Immunol; 2023 Jun; 8(84):eabl8881. PubMed ID: 37390223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
    Saulle I; Vicentini C; Clerici M; Biasin M
    Hum Immunol; 2021 Aug; 82(8):551-560. PubMed ID: 34116863
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Gutierrez-Hoffmann MG; O'Meally RN; Cole RN; Tiniakou E; Darrah E; Soloski MJ
    Front Med (Lausanne); 2020; 7():568. PubMed ID: 33043033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells.
    Gaglione SA; Rosales TJ; Schmidt-Hong L; Baker BM; Birnbaum ME
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2406615121. PubMed ID: 39042676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion.
    Zhan Y; Ye L; Ouyang Q; Yin J; Cui J; Liu K; Guo C; Zhang H; Zhai J; Zheng C; Guo A; Sun B
    J Med Virol; 2023 Sep; 95(9):e29113. PubMed ID: 37750416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft.
    Kampstra ASB; van Heemst J; Janssen GM; de Ru AH; van Lummel M; van Veelen PA; Toes REM
    Immunogenetics; 2019 Sep; 71(8-9):519-530. PubMed ID: 31520135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolving SARS-CoV-2 CD4
    Pogorelyy MV; Rosati E; Minervina AA; Mettelman RC; Scheffold A; Franke A; Bacher P; Thomas PG
    Cell Rep Med; 2022 Aug; 3(8):100697. PubMed ID: 35841887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies.
    Taylor HB; Klaeger S; Clauser KR; Sarkizova S; Weingarten-Gabbay S; Graham DB; Carr SA; Abelin JG
    Mol Cell Proteomics; 2021; 20():100116. PubMed ID: 34146720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Immunopeptidomics and Proteomics Study of SARS-CoV-2-Infected Calu-3 Cells Reveals Dynamic Changes in Allele-specific HLA Abundance and Antigen Presentation.
    Chen R; Fulton KM; Tran A; Duque D; Kovalchik K; Caron E; Twine SM; Li J
    Mol Cell Proteomics; 2023 Oct; 22(10):100645. PubMed ID: 37709257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach.
    Campbell KM; Steiner G; Wells DK; Ribas A; Kalbasi A
    bioRxiv; 2020 Jun; ():. PubMed ID: 32511325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.
    Shkurnikov M; Nersisyan S; Jankevic T; Galatenko A; Gordeev I; Vechorko V; Tonevitsky A
    Front Immunol; 2021; 12():641900. PubMed ID: 33732261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.